Day after day,
researches are being conduced in finding solutions to social situations and in pursuit of an improved quality of life. On March 9, 2015 the journal Aging Cell revealed a
study conducted by the Scripps Research Institute (TSRI), Mayo Clinic and
others, which demonstrated in animals the ability to significantly delay aging.
This research opens the door for increased life expectancy of human beings.
Professor Paul Robbins with Professor Laura Niedernhofer awaits the development
of a safe treatment with the studied drug that will: alleviate signs of
weakness, improve heart function and increase life expectancy. It is expected from the drug components to work effectively against disorders and diseases related to
aging, therefore improving the quality of life of people.
The clinical study was conducted with the combination of two senolytics agents:
dasatinib and quercetin. These agents are more efficient together; they kill senile
cells, those which stop dividing and increase with age, accelerating the
aging process. By killing these cells the lifespan of mice in the experiment increased, so it is expected that the same mechanism will be performed in humans.
It's amazing how we challenge nature with our progress in trying to have a better
quality of life. This study will continue developing in animals until we find a way to handle
this cellular mechanism in humans. Who would not like to extend their life a little?
... These "needs" of human beings is why scientific field broadens more and more.
Video retrived from: https://youtu.be/J2GPtZhos5Y
If you want
to read more about this research you can access online:
No comments:
Post a Comment